Eric Vivier | CIML and Innate Pharma in the spotlight with “NKP46″ published in “Science”
Bristol-Myers Squibb and Innate Pharma choose ATCG partners to organize a unique roundtable event including internationally renowned panel speakers to discuss the topic “Innate immunity: from revolutionary discovery to revolution in therapy.”
ATCG-PARTNERS supports the Paoli-Calmettes Institute in developing its translational medicine activities
ATCG-Partners contributes to the valorisation of translational medicine activities at Paoli-Calmettes Institute and its main therapeutic fields: haematology, breast cancers, digestive and urogenital cancers.
Visit the dedicated website: research.institutpaolicalmettes.fr
Tagged with: IPC Cancer
Categories
Derniers Tweets



